(NASDAQ: RCEL) Avita Medical's forecast annual revenue growth rate of 71.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 19.72%.
Avita Medical's revenue in 2025 is $60,099,000.On average, 1 Wall Street analysts forecast RCEL's revenue for 2025 to be $2,695,172,261, with the lowest RCEL revenue forecast at $2,695,172,261, and the highest RCEL revenue forecast at $2,695,172,261.
In 2026, RCEL is forecast to generate $3,369,227,503 in revenue, with the lowest revenue forecast at $3,369,227,503 and the highest revenue forecast at $3,369,227,503.